Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 59051-59100 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT07125963
Patient-Specific vs. Conventional Positioning in Sagittal Split Ramus Osteotomy
NARecruiting
30 participants
Started: Jan 25, 2024 · Completed: Oct 30, 2026
1 condition1 sponsor1 location
NCT06049342
A Trial to Evaluate the Safety, Tolerability, and Efficacy of NCR100 Injection in the Treatment of Subjects With KOA
PHASE1Not yet recruiting
12 participants
Started: Jan 25, 2024 · Completed: May 31, 2025
1 condition3 sponsors0 locations
NCT06491784
EXTRA-Meso (EXercise TheRApy in Mesothelioma) Feasibility
NARecruiting
40 participants
Started: Jan 25, 2024 · Completed: Jul 31, 2025
1 condition4 sponsors2 locations
NCT06343831
Quantitative Assessment of Autologous Fat Transfer
NARecruiting
15 participants
Started: Jan 25, 2024 · Completed: Dec 31, 2026
1 condition3 sponsors2 locations
NCT06276101
NWRD08 DNA Plasmid for HPV-16 and/or HPV-18 Related Cervical HSIL
PHASE1Recruiting
9 participants
Started: Jan 25, 2024 · Completed: Jul 30, 2025
1 condition1 sponsor1 location
NCT06212765
Oral Citrulline Supplementation in COPD Patients With Malnutrition
PHASE3Not yet recruiting
60 participants
Started: Jan 25, 2024 · Completed: Sep 25, 2026
2 conditions1 sponsor0 locations
NCT06196164
A RCT of Low MBO Drainage Strategies
NAActive, not recruiting
40 participants
Started: Jan 25, 2024 · Completed: Aug 31, 2026
3 conditions1 sponsor1 location
NCT05998889
Feasibility of a Combination of Graded Pain Exposure and Graded Motor Imagery in People With Complex Regional Pain Syndrome Type 1
NARecruiting
26 participants
Started: Jan 25, 2024 · Completed: May 31, 2025
1 condition2 sponsors1 location
NCT06808880
EXpanding Prenatal Cell Free DNA Screening Across moNogenic Disorders (EXPAND)
N/ARecruiting
4,000 participants
Started: Jan 25, 2024 · Completed: Feb 28, 2026
1 condition1 sponsor18 locations
NCT06195358
Mobile Health Intervention for Infants in Guatemala (18-m Intervention)
NARecruiting
220 participants
Started: Jan 25, 2024 · Completed: Jul 31, 2026
1 condition3 sponsors1 location
NCT06218004
Envafolimab Combined With Chemotherapy in Neoadjuvant and Conversion Therapy for Head and Neck Squamous Cell Carcinoma
PHASE2Not yet recruiting
40 participants
Started: Jan 25, 2024 · Completed: Dec 31, 2025
1 condition1 sponsor0 locations
NCT06242977
Efficacy of EMLA Cream Assisted Loco-sedation for Office-based Andrology Procedures
PHASE3Recruiting
72 participants
Started: Jan 25, 2024 · Completed: Aug 30, 2024
5 conditions1 sponsor1 location
NCT06224478
Assessment of Palatal Mucosal Thickness in Different Vertical Skeletal Pattern: a 3D Analysis
N/ANot yet recruiting
100 participants
Started: Jan 25, 2024 · Completed: Apr 15, 2024
1 condition1 sponsor0 locations
NCT05825950
Artificial Intelligence Prediction Tool in Non-muscle Invasive Bladder Cancer (NMIBC)
N/ARecruiting
600 participants
Started: Jan 25, 2024 · Completed: Sep 30, 2026
1 condition2 sponsors2 locations
NCT06175065
Safety, PK and PD Relationships of RLS-0071 in Patients With Acute Exacerbation of Chronic Obstructive Pulmonary Disease
PHASE2Active, not recruiting
24 participants
Started: Jan 25, 2024 · Completed: Jun 30, 2025
1 condition1 sponsor4 locations
NCT06210256
Compared Unidirectional Valve Apparatus and Occluding the Non-ventilated Endobronchial Lumen for Lung Collapse.
NANot yet recruiting
192 participants
Started: Jan 25, 2024 · Completed: Jun 25, 2024
2 conditions1 sponsor1 location
NCT06264934
An Investigation Into Dielectric Assessment of Permittivity and Conductivity in Human Using a Novel Electrical Capacitance Tomography Scanner
N/ARecruiting
90 participants
Started: Jan 25, 2024 · Completed: Dec 31, 2024
2 conditions2 sponsors1 location
NCT05773898
Contribution of Psychological Autopsy to the Understanding of Suicidal Behaviors in French Overseas Territories
N/ARecruiting
150 participants
Started: Jan 25, 2024 · Completed: Apr 30, 2025
3 conditions14 sponsors1 location
NCT06174480
Evaluation of the Response to Hypoxia at Rest and During Exercise in a Healthy Subject After a Cryostimulation Exposure
NANot yet recruiting
35 participants
Started: Jan 25, 2024 · Completed: May 25, 2025
6 conditions2 sponsors2 locations
NCT06206733
ASKB589 in Combination With CAPOX and PD-1 Inhibitor in Patients With Advanced or Metastatic GC/GEJ Adenocarcinoma
PHASE3Recruiting
780 participants
Started: Jan 25, 2024 · Completed: Dec 30, 2028
2 conditions2 sponsors1 location
NCT06234670
Risk Factors and A Prediction Model of Recurrence of Uterine Fibroids
N/ANot yet recruiting
3,200 participants
Started: Jan 25, 2024 · Completed: Jan 1, 2025
2 conditions2 sponsors1 location
NCT06466785
A Phase 3 Study of Efepoetin Alfa for Treatment of Anemia in Patients With Chronic Kidney Disease on Dialysis
PHASE3Recruiting
429 participants
Started: Jan 25, 2024 · Completed: Sep 30, 2027
1 condition2 sponsors9 locations
NCT06230965
Clinical Study of Lung Protective Ventilation Strategies and Tumor Microenvironment
NAEnrolling by invitation
60 participants
Started: Jan 25, 2024 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT06225596
Study BT8009-230 in Participants With Locally Advanced or Metastatic Urothelial Cancer (Duravelo-2)
PHASE2/PHASE3Recruiting
956 participants
Started: Jan 24, 2024 · Completed: Dec 31, 2030
1 condition1 sponsor172 locations
NCT06689189
Detection of Sepsis Occurrence by Using Blood Fluorescence
N/ARecruiting
800 participants
Started: Jan 24, 2024 · Completed: Oct 1, 2027
2 conditions2 sponsors1 location
NCT06139523
Optimize Pediatric OCT Imaging
N/ARecruiting
30 participants
Started: Jan 24, 2024 · Completed: Dec 31, 2026
3 conditions1 sponsor1 location
NCT06110195
Study of Xevinapant With Radiation and Chemotherapy for Patients With Head and Neck Cancer
PHASE1Active, not recruiting
42 participants
Started: Jan 24, 2024 · Completed: Oct 31, 2027
3 conditions2 sponsors1 location
NCT05988814
Trial Evaluating the Efficacy and the Safety of FOLFIRINOX3 Treatment in Patients With Unresectable Locally Advanced or Metastatic Pancreatic Cancer in First Line of Chemotherapy
PHASE2Recruiting
90 participants
Started: Jan 24, 2024 · Completed: Jul 24, 2029
1 condition1 sponsor1 location
NCT05535855
UCD19 CAR T Therapy in Adults With B-ALL and MRD Positivity in CR1
PHASE1Recruiting
29 participants
Started: Jan 24, 2024 · Completed: Jun 30, 2030
2 conditions1 sponsor1 location
NCT05891613
A Study of Liposomal Bupivacaine Versus 0.25% Bupivacaine Hydrochloride Post Breast Reduction
PHASE4Active, not recruiting
42 participants
Started: Jan 24, 2024 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT06436040
Mechanism Study to Investigate Difference in Efficacy of Neoadjuvant Chemoimmunotherapy in Lung Squamous Cell Carcinoma
N/ARecruiting
40 participants
Started: Jan 24, 2024 · Completed: May 16, 2025
3 conditions1 sponsor1 location
NCT06112743
A Study to Evaluate Mavacamten Impact on Myocardial Structure in Participants With Symptomatic Obstructive Hypertrophic Cardiomyopathy
PHASE4Active, not recruiting
63 participants
Started: Jan 24, 2024 · Completed: Jul 9, 2026
1 condition1 sponsor23 locations
NCT06138587
Preemptive CIML NK Cell Therapy After Hematopoietic Stem Cell Transplantation
PHASE1Recruiting
15 participants
Started: Jan 24, 2024 · Completed: Nov 30, 2027
6 conditions1 sponsor2 locations
NCT05733312
Extracellular Impact of Ultrasound-induced Blood-brain Barrier Disruption
NARecruiting
6 participants
Started: Jan 24, 2024 · Completed: Jan 15, 2027
1 condition1 sponsor1 location
NCT06138353
Shuxuening Injection for the Prevention of CVS in Patients With aSAH(SXN-CVS)
PHASE2/PHASE3Recruiting
50 participants
Started: Jan 24, 2024 · Completed: Nov 30, 2025
1 condition1 sponsor1 location
NCT06572046
STOP-HSP.Net: a Registry for Hereditary Spastic Paraplegia as an Integration Tool for Future Therapeutic Strategies
N/ARecruiting
500 participants
Started: Jan 24, 2024 · Completed: Dec 31, 2029
1 condition7 sponsors1 location
NCT06212388
Allogeneic Gammadelta T Cells Combined With Interferon-α1b or PD-1 Monoclonal Antibody in Stage III-IV Amenable to Surgical Resection Melanoma
EARLY_PHASE1Not yet recruiting
10 participants
Started: Jan 24, 2024 · Completed: Oct 30, 2028
1 condition2 sponsors0 locations
NCT06132581
Causal Role of Delta-beta Coupling for Goal-directed Behavior in Anhedonic Depression
NARecruiting
72 participants
Started: Jan 24, 2024 · Completed: Jul 31, 2026
2 conditions2 sponsors1 location
NCT06134154
Safety and Efficacy of Carbon Dioxide Gas for Endoscopy
NARecruiting
350 participants
Started: Jan 24, 2024 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT06088537
Isolated Rectal Bleeding in Newborns : Allergic Proctocolitis or Neonatal Colitis Transient - COLON Study
N/ARecruiting
40 participants
Started: Jan 24, 2024 · Completed: Jul 24, 2027
1 condition1 sponsor1 location
NCT06516146
Impact 360 for Healthy Agers
NARecruiting
60 participants
Started: Jan 24, 2024 · Completed: Jan 5, 2025
1 condition2 sponsors1 location
NCT06222827
Study to Evaluate the Efficacy and Safety of Satralizumab in FSHD1
PHASE2Active, not recruiting
46 participants
Started: Jan 24, 2024 · Completed: Mar 31, 2027
1 condition1 sponsor2 locations
NCT04260854
Bupivacaine Hydrochloride for Pain Control in Cutaneous Surgery
PHASE1Enrolling by invitation
100 participants
Started: Jan 24, 2024 · Completed: Jun 30, 2025
1 condition1 sponsor1 location
NCT06065449
A Phase III Randomized Trial Comparing Stereotactic Body Radiation Therapy (SBRT) vs Conventional Palliative Radiation Therapy for Painful Bone Metastases
PHASE3Recruiting
220 participants
Started: Jan 24, 2024 · Completed: Jun 27, 2027
1 condition1 sponsor1 location
NCT06206954
Supporting Decisions on Lifestyle Change
NAEnrolling by invitation
864 participants
Started: Jan 24, 2024 · Completed: Jul 30, 2028
1 condition2 sponsors1 location
NCT06321341
Efficacy and Safety of Vespireit, Prolonged-release Tablets, in Patients With Autonomic Dysfunction Syndrome Accompanied by Functional Vertigo
PHASE4Recruiting
160 participants
Started: Jan 24, 2024 · Completed: Dec 31, 2026
2 conditions1 sponsor4 locations
NCT05564936
The ME&MG Digital Solution for Autonomous Assessment of Myasthenia Gravis
NARecruiting
144 participants
Started: Jan 24, 2024 · Completed: Sep 24, 2026
1 condition1 sponsor19 locations
NCT06265675
Comparison of the Efficacy of Phenol Block and Corticosteroid-Local Anesthetic Block Applied to the Genicular Nerve
NARecruiting
88 participants
Started: Jan 24, 2024 · Completed: Jun 24, 2025
1 condition1 sponsor1 location
NCT06404905
Clinical Trial of BT02 in Patients With Advanced Solid Tumors
PHASE1Recruiting
60 participants
Started: Jan 24, 2024 · Completed: Dec 31, 2024
1 condition1 sponsor1 location
NCT05223816
An Open-Label, Multiple-Center, Phase IIa/IIb Clinical Trial to Evaluate the Efficacy, Safety and Tolerability of VG161 as Monotherapy and in Combination With Nivolumab for Treatment of Patients With Hepatocellular Carcinoma or Intrahepatic Cholangiocarcinoma
PHASE2Recruiting
97 participants
Started: Jan 24, 2024 · Completed: Dec 31, 2025
2 conditions1 sponsor3 locations